Table 1 Epidemiologic and histologic characterizations between women with negative or positive LN
EC FFPE primary tumor Negative LN n=27 | EC FFPE primary tumor Positive LN n=9 | P-value | |
|---|---|---|---|
Age, median (IQR) | 72 (65–78) | 68 (64–76) | 0.84 |
Diabetes n (%) | 3 (11.1%) | 0 (0%) | 0.56 |
Dyslipidemia n (%) | 3 (15.8%) | 1 (20%) | 1 |
Parity, median (IQR) | 2 (1–3) | 1 (0–3) | 0.85 |
BMI, median (IQR) | 24 (22–27) | 25 (20–29) | 0.92 |
FIGO Stage, n (%) | |||
IA | 13 (48.1%) | 4 (44.4%) | 1 |
IB | 14 (51.9%) | 5 (55.6%) | |
Histologic grade, n (%) | |||
Grade 1 | 9 (33.3%) | 3 (33.3%) | 1 |
Grade 2 | 18 (66.7%) | 6 (66.7%) | |
Tumor size (mm), median (IQR) | 40 (25–40) | 40 (25–42) | 0.82 |
ESMO risk group, n (%) | |||
Low risk | 13 (48.1%) | 4 (44.4%) | 1 |
Intermediate risk | 14 (51.9%) | 5 (55.6%) | |
LVSI, n (%) | |||
Yes | 9 (33.3%) | 3 (33.3%) | 1 |
No | 18 (66.6%) | 6 (66.6%) | |
Time between surgery and sample analysis (months), median (IQR) | 32 (21–79) | 30 (15–60) | 0.95 |
